Ryan Deschner
Stock Analyst at Raymond James
(4.79)
# 508
Out of 4,457 analysts
65
Total ratings
70.9%
Success rate
44.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ryan Deschner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHV Achieve Life Sciences | Initiated Coverage: Buy | $20 | $6.23 | +221.03% | 1 | Jun 26, 2026 | |
| PRQR ProQR Therapeutics | Maintained: Buy | $14 → $10 | $1.83 | +446.45% | 2 | Jun 26, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | n/a | $39.54 | - | 2 | Jun 24, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | n/a | $43.15 | - | 6 | Jun 24, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | n/a | $95.68 | - | 5 | Jun 12, 2026 | |
| ADMA ADMA Biologics | Initiated Coverage: Buy | $21 | $8.37 | +150.90% | 1 | Jun 10, 2026 | |
| LQDA Liquidia | Maintained: Buy | n/a | $75.12 | - | 12 | Jun 4, 2026 | |
| IFRX InflaRx | Maintained: Buy | $9 | $2.28 | +294.74% | 4 | May 13, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $110 → $165 | $122.94 | +34.22% | 4 | May 7, 2026 | |
| KRRO Korro Bio | Upgraded: Buy | $23 | $13.20 | +74.31% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.56 | - | 11 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $54 → $143 | $154.84 | -7.65% | 2 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.91 | - | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $18.63 | +44.93% | 5 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $12 | $5.23 | +129.45% | 4 | Aug 5, 2025 |
Achieve Life Sciences
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $6.23
Upside: +221.03%
ProQR Therapeutics
Jun 26, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $1.83
Upside: +446.45%
Viking Therapeutics
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $39.54
Upside: -
Vera Therapeutics
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $43.15
Upside: -
Dianthus Therapeutics
Jun 12, 2026
Maintained: Buy
Price Target: n/a
Current: $95.68
Upside: -
ADMA Biologics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $8.37
Upside: +150.90%
Liquidia
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $75.12
Upside: -
InflaRx
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $2.28
Upside: +294.74%
Mirum Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $110 → $165
Current: $122.94
Upside: +34.22%
Korro Bio
Mar 13, 2026
Upgraded: Buy
Price Target: $23
Current: $13.20
Upside: +74.31%
Jan 9, 2026
Maintained: Buy
Price Target: n/a
Current: $8.56
Upside: -
Nov 19, 2025
Upgraded: Buy
Price Target: $54 → $143
Current: $154.84
Upside: -7.65%
Oct 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $1.91
Upside: -
Aug 8, 2025
Maintained: Buy
Price Target: $29 → $27
Current: $18.63
Upside: +44.93%
Aug 5, 2025
Maintained: Buy
Price Target: $11 → $12
Current: $5.23
Upside: +129.45%